Clinical trial
A Long Term Study of Sibutramine and the Role of Obesity Management in Relation…
NCT00234832 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00234832 |
|---|---|
| Title | A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients |
| Official title | Sibutramine Cardiovascular Morbidity/Mortality Outcomes Study in Overweight or Obese Subjects at Risk of a Cardiovascular Event |
| Acronym | SCOUT |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | Sibutramine hydrochloride, Placebo |
| Enrollment | 10,777 |
| Start date | Jan 1, 2003 |
| Primary completion | Mar 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Oct 10, 2005 |
| Last update posted | May 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: